Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.2.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.75NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.411NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.217NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.35NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.17 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.626NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.629NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.61 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GC.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.524NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.79.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used